AXONIS THERAPEUTICS, INC.
Reviving Neurons - Restoring Control
BOSTON, United States · Founded 2020 · $115.0M raised
- Headquarters
- BOSTON, Massachusetts
- Employees
- 11–50
- Founded
- 2020
- Website
- axonis.us
- Total Funding
- $115.0M
- Last Round
- $115.0M Series AOct 2024
- Rounds
- 1
About
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, a critical mediator of inhibition within the brain. The company translates breakthrough discoveries spun out from Boston Children's Hospital, Harvard, and Laval University into oral therapeutics for currently incurable neurological disorders including pain, epilepsy, and psychiatric conditions. Axonis raised $115M in a Series A round in October 2024 to fund Phase I clinical trials.
Summary
AXONIS THERAPEUTICS, INC. is a company based in BOSTON, United States, founded in 2020. It has raised $115.0M in total across 1 round, most recently a $115.0M Series A round in Oct 2024. Investors include Cormorant Asset Management, venBIO Partners and Sofinnova Investments.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
